You just read:

Hagens Berman Alerts Investors in AbbVie Inc. (ABBV) to the Firm's Investigation of Possible Humira-Related Health Insurance Fraud and Disclosure Violations

News provided by

Hagens Berman Sobol Shapiro LLP

Sep 21, 2018, 17:05 ET